Lower KV7.5 Potassium Channel Subunit Expression in an Animal Model of Paroxysmal Dystonia

E-ISSN： 1996-3181|15|1|95-101

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.1, 2016-02, pp. : 95-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis

By Richter A. Loscher W.

European Journal of Pharmacology, Vol. 369, Iss. 3, 1999-03 ,pp. : 335-338

Elsevier

Access to resources Recommend Favorite

Drug Discoveries Towards Kv1.5 Potassium Channel

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-03 ,pp. : 339-347

Bentham Science Publishers

Access to resources Recommend Favorite

Kv1.3 potassium channel blockade as an approach to insulin resistance

By Desir Gary V

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 571-579

Informa Healthcare

Access to resources Recommend Favorite

The Kv7 potassium channel activator retigabine decreases alcohol consumption in rats

By Knapp Clifford M. O’Malley Matthew Datta Subimal Ciraulo Domenic A.

The American Journal of Drug and Alcohol Abuse, Vol. 40, Iss. 3, 2014-05 ,pp. : 244-250

Informa Healthcare

Access to resources Recommend Favorite

Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840

By Wulff Heike

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1759-1765

Informa Healthcare

Access to resources Recommend Favorite